Derm-Biome Pharmaceuticals, Inc. files a US provisional patent for a new generation of natural product-based derivatives and their uses for treating chronic inflammatory skin conditions
…
Derm-Biome Pharmaceuticals, Inc. adds skin disease and microbiome specialists Drs. Youwen Zhou and Andy Sham to Its Newly Created Scientific Advisory Board
…
Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Psoriasis
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that one of its topical drugs produced significant, and dose dependent inhibitory effects in a well established mouse […]
Derm-Biome Pharmaceuticals, Inc raises pre-seed funding, spins out new company focused on chronic inflammatory diseases
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin diseases and healthy ageing, is pleased to announce that it has raised $500,000 in pre-seed funding, monies that will allow it to advance its anti-aging (skin […]
Derm-Biome Pharmaceuticals, Inc. Reports Positive Results from a Preclinical Study In Atopic Dermatitis
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] VANCOUVER, British Columbia, March 24, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that one of its topical drugs produced significant, and dose dependent inhibitory effects in a well established […]
Skin health startup Derm-Biome Pharmaceuticals, Inc. to receive funding from the Government of Canada
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text]VANCOUVER, British Columbia, July 09, 2019 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health, is excited to announce that it will receive up to $149,000 in research and development funding from the National Research Council of Canada Industrial Research […]
Derm-Biome Pharmaceuticals Inc Seeks Collaborators To Test Promising Anti-Tumor Compound On Skin Cancer In Dogs Cats And Horses.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text] March 20, 2019 VANCOUVER, British Columbia — Derm-Biome Pharmaceuticals Inc, a Vancouver based start-up biopharmaceutical company, will be reaching out to the world’s top veterinary researchers and veterinary schools for collaborative opportunities to show efficacy of its lead compound NVX-207, in the underserved area of cancers in […]
Derm-Biome Pharmaceuticals Inc. announces an exciting collaboration with Harvard Medical School
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text] February 22, 2019 VANCOUVER, British Columbia — Derm-Biome Pharmaceuticals Inc, a Vancouver based start-up biopharmaceutical company, is excited to announce that it will be collaborating with Dr. Anna Mandinova and the Department of Dermatology at Harvard Medical School. “I reached out to Poul (Dr. Sorensen) when I […]
Derm-Biome Pharmaceuticals Inc. commences testing its proprietary compounds on skin microbiome targets.
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] October 26, 2018 VANCOUVER, British Columbia — Vancouver based microbiome startup Derm-Biome Pharmaceuticals Inc. is excited to announce that it has contracted the Centre for Drug Research and Development (CDRD) to commence testing its patented compounds on various pathogens. Lead compound DB-207 shows significant potential in patients […]
Novelix Pharmaceuticals – Company Overview
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] October 23, 2009 Novelix Pharmaceuticals, Inc. (Novelix), is a private, La Jolla based, biotechnology company committed to developing innovative, proprietary, dermatology products with large market potential to treat serious skin diseases. The company’s main focus is the development of NVX-207, a novel, topical drug candidate with the […]